Skip to main content
Erschienen in: International Urology and Nephrology 5/2016

02.02.2016 | Nephrology - Original Paper

Factors impacting sodium restriction in patients with chronic kidney disease: a cohort study from a Chinese center

verfasst von: Yu Wang, Fangfang Yu, Yunfei Bao, Luxia Zhang, Hong Wang

Erschienen in: International Urology and Nephrology | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Sodium restriction is important for the management of chronic kidney disease (CKD). The present study evaluated the factors impacting dietary sodium restriction in a cohort of Chinese patients with CKD.

Methods

A questionnaire on dietary sodium restriction was administered to patients with non-dialysis CKD who visited our CKD clinic from September 2014 to March 2015. Twenty-four-hour urinary sodium excretion (24-h UNa) was measured. Logistic regression was performed to examine the association between patient characteristics and sodium restriction.

Results

Two hundred and twenty-nine patients were included in the final analysis. Most of the patients (97.7 %) declared their awareness of the necessity of sodium restriction, but 27.3 % of them chose an incorrect sodium restriction limit. Most of the patients (85.2 %) also reported that they had taken actions to reduce their sodium consumption, with intolerance of sodium restriction as the most common reason for taking no actions. Only 42 patients (18.3 %) had a 24-h UNa of <100 mmol. Multivariable logistic regression showed that age and the use of condiments were independently associated with successful sodium restriction [odds ratio (95 % confidence interval) 1.04 (1.01–1.07), p = 0.006 and 0.38 (0.16–0.88), p = 0.023, respectively]. Most of the patients (83.0 %) did not know how to estimate their sodium intake from condiments.

Conclusions

This study indicates that there is much room for improvement in dietary sodium restriction in Chinese patients with CKD. Condiments as a hidden source of sodium intake should be stressed in the education of these patients.
Literatur
1.
Zurück zum Zitat Vegter S, Perna A, Postma MJ, Navis G, Remuzzi G, Ruggenenti P (2012) Sodium intake, ACE inhibition, and progression to ESRD. J Am Soc Nephrol 23(1):165–173CrossRefPubMedPubMedCentral Vegter S, Perna A, Postma MJ, Navis G, Remuzzi G, Ruggenenti P (2012) Sodium intake, ACE inhibition, and progression to ESRD. J Am Soc Nephrol 23(1):165–173CrossRefPubMedPubMedCentral
2.
3.
Zurück zum Zitat D’Elia L, Rossi G, Schiano di Cola M, Savino I, Galletti F, Strazzullo P (2015) Meta-analysis of the effect of dietary sodium restriction with or without concomitant renin–angiotensin–aldosterone system-inhibiting treatment on albuminuria. Clin J Am Soc Nephrol 10(9):1542–1552CrossRefPubMed D’Elia L, Rossi G, Schiano di Cola M, Savino I, Galletti F, Strazzullo P (2015) Meta-analysis of the effect of dietary sodium restriction with or without concomitant renin–angiotensin–aldosterone system-inhibiting treatment on albuminuria. Clin J Am Soc Nephrol 10(9):1542–1552CrossRefPubMed
4.
Zurück zum Zitat Agarwal R (2012) Resistant hypertension and the neglected antihypertensive: sodium restriction. Nephrol Dial Transplant 27(11):4041–4045CrossRefPubMed Agarwal R (2012) Resistant hypertension and the neglected antihypertensive: sodium restriction. Nephrol Dial Transplant 27(11):4041–4045CrossRefPubMed
5.
Zurück zum Zitat Sinnakirouchenan R, Kotchen TA (2014) Role of sodium restriction and diuretic therapy for “resistant” hypertension in chronic kidney disease. Semin Nephrol 34(5):514–519CrossRefPubMed Sinnakirouchenan R, Kotchen TA (2014) Role of sodium restriction and diuretic therapy for “resistant” hypertension in chronic kidney disease. Semin Nephrol 34(5):514–519CrossRefPubMed
6.
Zurück zum Zitat McMahon EJ, Campbell KL, Bauer JD, Mudge DW (2015) Altered dietary salt intake for people with chronic kidney disease. Cochrane Database Syst Rev 2:CD010070PubMed McMahon EJ, Campbell KL, Bauer JD, Mudge DW (2015) Altered dietary salt intake for people with chronic kidney disease. Cochrane Database Syst Rev 2:CD010070PubMed
7.
Zurück zum Zitat Humalda JK, Navis G (2014) Dietary sodium restriction: a neglected therapeutic opportunity in chronic kidney disease. Curr Opin Nephrol Hypertens 23(6):533–540CrossRefPubMedPubMedCentral Humalda JK, Navis G (2014) Dietary sodium restriction: a neglected therapeutic opportunity in chronic kidney disease. Curr Opin Nephrol Hypertens 23(6):533–540CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Campbell KL, Johnson DW, Bauer JD et al (2014) A randomized trial of sodium-restriction on kidney function, fluid volume and adipokines in CKD patients. BMC Nephrol 15:57CrossRefPubMedPubMedCentral Campbell KL, Johnson DW, Bauer JD et al (2014) A randomized trial of sodium-restriction on kidney function, fluid volume and adipokines in CKD patients. BMC Nephrol 15:57CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat de Brito-Ashurst I, Perry L, Sanders TA et al (2013) The role of salt intake and salt sensitivity in the management of hypertension in South Asian people with chronic kidney disease: a randomised controlled trial. Heart 99(17):1256–1260CrossRefPubMedPubMedCentral de Brito-Ashurst I, Perry L, Sanders TA et al (2013) The role of salt intake and salt sensitivity in the management of hypertension in South Asian people with chronic kidney disease: a randomised controlled trial. Heart 99(17):1256–1260CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Weir MR, Townsend RR, Fink JC et al (2012) Urinary sodium is a potent correlate of proteinuria: lessons from the chronic renal insufficiency cohort study. Am J Nephrol 36(5):397–404CrossRefPubMedPubMedCentral Weir MR, Townsend RR, Fink JC et al (2012) Urinary sodium is a potent correlate of proteinuria: lessons from the chronic renal insufficiency cohort study. Am J Nephrol 36(5):397–404CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Inker LA, Astor BC, Fox CH et al (2014) KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis 63(5):713–735CrossRefPubMed Inker LA, Astor BC, Fox CH et al (2014) KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis 63(5):713–735CrossRefPubMed
12.
Zurück zum Zitat (2000) K/DOQI clinical practice guidelines for nutrition in chronic renal failure. Am J Kidney Dis 35(6 Suppl 2):S1–S140 (2000) K/DOQI clinical practice guidelines for nutrition in chronic renal failure. Am J Kidney Dis 35(6 Suppl 2):S1–S140
13.
Zurück zum Zitat Kutlugün AA, Arıcı M, Yıldırım T et al (2011) Daily sodium intake in chronic kidney disease patients during nephrology clinic follow-up: an observational study with 24-hour urine sodium measurement. Nephron Clin Pract 118(4):c361–c366CrossRefPubMed Kutlugün AA, Arıcı M, Yıldırım T et al (2011) Daily sodium intake in chronic kidney disease patients during nephrology clinic follow-up: an observational study with 24-hour urine sodium measurement. Nephron Clin Pract 118(4):c361–c366CrossRefPubMed
15.
Zurück zum Zitat Vennegoor MA (2009) Salt restriction and practical aspects to improve compliance. J Ren Nutr 19(1):63–68CrossRefPubMed Vennegoor MA (2009) Salt restriction and practical aspects to improve compliance. J Ren Nutr 19(1):63–68CrossRefPubMed
16.
Zurück zum Zitat Zhang R, Wang Z, Fei Y et al (2015) The difference in nutrient intakes between Chinese and Mediterranean, Japanese and American diets. Nutrients 7(6):4661–4688CrossRefPubMedPubMedCentral Zhang R, Wang Z, Fei Y et al (2015) The difference in nutrient intakes between Chinese and Mediterranean, Japanese and American diets. Nutrients 7(6):4661–4688CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Du S, Neiman A, Batis C et al (2014) Understanding the patterns and trends of sodium intake, potassium intake, and sodium to potassium ratio and their effect on hypertension in China. Am J Clin Nutr 99:334–343CrossRefPubMedPubMedCentral Du S, Neiman A, Batis C et al (2014) Understanding the patterns and trends of sodium intake, potassium intake, and sodium to potassium ratio and their effect on hypertension in China. Am J Clin Nutr 99:334–343CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat de Brito-Ashurst I, Perry L, Sanders TA, Thomas JE, Yaqoob MM, Dobbie H (2011) Barriers and facilitators of dietary sodium restriction amongst Bangladeshi chronic kidney disease patients. J Hum Nutr Diet 24(1):86–95CrossRefPubMed de Brito-Ashurst I, Perry L, Sanders TA, Thomas JE, Yaqoob MM, Dobbie H (2011) Barriers and facilitators of dietary sodium restriction amongst Bangladeshi chronic kidney disease patients. J Hum Nutr Diet 24(1):86–95CrossRefPubMed
19.
Zurück zum Zitat Wang Y, Sun L, Wang H et al (2012) Importance and benefits of dietary sodium restriction in the management of chronic kidney disease patients: experience from a single Chinese center. Int Urol Nephrol 44(2):549–556CrossRef Wang Y, Sun L, Wang H et al (2012) Importance and benefits of dietary sodium restriction in the management of chronic kidney disease patients: experience from a single Chinese center. Int Urol Nephrol 44(2):549–556CrossRef
20.
Zurück zum Zitat World Health Organization (2011) Strategies to monitor and evaluate population sodium consumption and sources of sodium in the diet: report of a joint technical meeting convened by WHO and the Government of Canada. World Health Organization, Geneva World Health Organization (2011) Strategies to monitor and evaluate population sodium consumption and sources of sodium in the diet: report of a joint technical meeting convened by WHO and the Government of Canada. World Health Organization, Geneva
21.
Zurück zum Zitat (2013) The 2012 kidney disease: improving global outcomes (KDIGO) clinical practice guideline for evaluation and management of CKD. Kidney Int Suppl 3(1):19–62 (2013) The 2012 kidney disease: improving global outcomes (KDIGO) clinical practice guideline for evaluation and management of CKD. Kidney Int Suppl 3(1):19–62
23.
Zurück zum Zitat Stolarz-Skrzypek K, Staessen JA (2015) Reducing salt intake for prevention of cardiovascular disease—times are changing. Adv Chronic Kidney Dis 22(2):108–115CrossRefPubMed Stolarz-Skrzypek K, Staessen JA (2015) Reducing salt intake for prevention of cardiovascular disease—times are changing. Adv Chronic Kidney Dis 22(2):108–115CrossRefPubMed
24.
Zurück zum Zitat Kalogeropoulos AP, Georgiopoulou VV, Murphy RA et al (2015) Dietary sodium content, mortality, and risk for cardiovascular events in older adults: the Health, Aging, and Body Composition (Health ABC) study. JAMA Intern Med 175(3):410–419CrossRefPubMedPubMedCentral Kalogeropoulos AP, Georgiopoulou VV, Murphy RA et al (2015) Dietary sodium content, mortality, and risk for cardiovascular events in older adults: the Health, Aging, and Body Composition (Health ABC) study. JAMA Intern Med 175(3):410–419CrossRefPubMedPubMedCentral
Metadaten
Titel
Factors impacting sodium restriction in patients with chronic kidney disease: a cohort study from a Chinese center
verfasst von
Yu Wang
Fangfang Yu
Yunfei Bao
Luxia Zhang
Hong Wang
Publikationsdatum
02.02.2016
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 5/2016
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-016-1223-1

Weitere Artikel der Ausgabe 5/2016

International Urology and Nephrology 5/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

11.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Im Battle of Experts traten zwei Experten auf dem Diabeteskongress gegeneinander an: Die eine vertrat die Auffassung „Sport statt Spritze“ bei Adipositas und Typ-2-Diabetes, der andere forderte „Spritze statt Sport!“ Am Ende waren sie sich aber einig: Die Kombination aus beidem erzielt die besten Ergebnisse.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.